Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/355915
Type: Artigo
Title: Comparative expression of cyclooxygenase 2 and Ki67 in amelanotic and conventional oral melanoma
Author: Soares, Ciro Dantas
Hernandez-Guerrero, Juan Carlos
Andrade, Bruno Augusto Benevenuto de
Romañach, Mário José
Mosqueda-Taylor, Adalberto
Carlos, Román
Macedo, Madja Ruanna Soares
Almeida, Oslei Paes de
Jorge, Jacks
Abstract: Oral melanomas have some histopathological resemblance with its cutaneous counterpart; however, an aggressive behavior is more common in tumors that occur in the oral cavity. Several markers have been suggested as indicative of tumoral progression and aggressiveness, such as cyclooxygenase 2 (COX-2) and Ki67. In this study, we have compared the expression of COX-2 and Ki67 in a series of amelanotic (n=7) and melanotic oral melanomas (n=22). The cases were selected from 4 pathology laboratories and submitted to the immunohistochemical (IHC) reactions. We analyzed the IHC staining based on a qualitative – using visual scores; and a computer-assisted method (quantitative) using scanned slides and software for digital analysis. COX-2 was expressed in all oral melanomas; however, its intensity was significantly higher in the amelanotic ones (P<0.001). Similarly, a high Ki67-positivity index was observed in the amelanotic than melanotic ones (P<0.001). Based on these results, we suggest that amelanotic oral melanomas have marked pro-inflammatory and high-proliferative phenotype, justifying their more aggressive behavior compared with the melanotic ones
Subject: Melanoma
Country: Espanha
Editor: Medicina Oral
Rights: Fechado
Identifier DOI: 10.4317/medoral.23737
Address: https://www.medoraljced.com/medoral/revista/2020/November/25/
Date Issue: 2020
Appears in Collections:FOP - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.